S1602

A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-Naïve High-Grade Non-Muscle Invasive Bladder Cancer
Contact phone
Tracy, RN 517.364.2835
Principal investigator
Gordan Srkalovic
Trial Category
Cancer
Trial SubCategory
Bladder, Genitourinary GU